Heron Therapeutics
HRTX
#7891
Rank
A$0.41 B
Marketcap
$2.74
Share price
-1.73%
Change (1 day)
-25.05%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.76

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.88. In 2022 the company made an earnings per share (EPS) of -$2.78 an increase over its 2021 EPS that were of -$3.62.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.76-36.64%
2022-$2.78-23.11%
2021-$3.62-10%
2020-$4.02-0%
2019-$4.021.21%
2018-$3.97-32.7%
2017-$5.91-19.34%
2016-$7.3254.76%
2015-$4.731.73%
2014-$4.65-16.23%
2013-$5.5591.67%
2012-$2.90-31.45%
2011-$4.23-27.06%
2010-$5.79-43.75%
2009-$10.30-57.33%
2008-$24.14-82.92%
2007-$141.3020.61%
2006-$117.16175.76%
2005-$42.49-21.43%
2004-$54.07100%
2003-$27.04-38.24%
2002-$43.77161.54%
2001-$16.74-106.46%
2000$258.932051.55%
1999$12.03839.73%
1998$1.28-105.48%
1997-$23.39-88.16%
1996-$197.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.09-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.23-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.62 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.53-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.66 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA